下肢旁路术中出血量与围术期输血独立且联合与术后并发症和死亡相关
基于VQI数据库2014–2023年36,019例因慢性肢体威胁性缺血行下肢旁路术的患者,以225 mL为术中估计出血量(EBL)阈值分组。高EBL未输血、低EBL输血及高EBL输血者术后30天死亡、心梗、卒中和复合终点风险均升高,高EBL合并输血者风险最高,且EBL与输血存在显著交互作用。
要点
- 高EBL(≥225 mL)未输血者30天死亡AOR 1.26、心梗AOR 1.88、卒中AOR 1.58。
- 低EBL输血者30天死亡AOR 2.46、心梗AOR 6.57、卒中AOR 2.75。
- 高EBL合并输血者风险最高,30天死亡AOR 2.54、心梗AOR 7.39。
核心结论
- 因CLTI行下肢旁路术的患者中,术中EBL和围术期pRBC输血均独立且联合与术后并发症和死亡风险升高相关。
- EBL与输血可作为围术期风险标志,支持进一步研究减少失血策略和个体化输血实践。
研究设计与样本
- 回顾性队列研究,使用血管外科学会血管质量倡议(VQI)数据库。
- 纳入2014–2023年因CLTI行下肢旁路术的患者,共36,019例手术。
- 通过ROC分析确定预测输血的EBL最佳阈值为225 mL(AUC 0.72),据此分为低EBL(<225 mL)和高EBL(≥225 mL)组。
- 采用多变量逻辑回归评估EBL与输血四组间的调整关联,并单独模型评估交互作用。
主要发现
- 58.5%为低EBL,41.5%为高EBL。
- 高EBL未输血者30天死亡AOR 1.26(95%CI 1.01–1.59)、心梗AOR 1.88(95%CI 1.48–2.39)、卒中AOR 1.58(95%CI 1.09–2.29)、复合终点AOR 1.51(95%CI 1.29–1.78)。
- 低EBL输血者30天死亡AOR 2.46(95%CI 1.95–3.10)、心梗AOR 6.57(95%CI 5.26–8.21)、卒中AOR 2.75(95%CI 1.84–4.12)、复合终点AOR 4.08(95%CI 3.48–4.78)。
- 高EBL合并输血者30天死亡AOR 2.54(95%CI 2.09–3.08)、心梗AOR 7.39(95%CI 6.08–8.98)、卒中AOR 3.79(95%CI 2.76–5.21)、复合终点AOR 4.42(95%CI 3.87–5.05)。
- 正式交互检验显示EBL与输血之间存在显著交互作用。
关键数值与推荐
- EBL预测输血的阈值为225 mL(AUC 0.72)。
- 低EBL定义为<225 mL,高EBL定义为≥225 mL。
- 主要结局包括心肌梗死、卒中、30天死亡和复合终点。
临床怎么用
- 下肢旁路术中应将EBL≥225 mL和围术期输血视为术后不良事件的风险标志。
- 对高EBL或需输血患者可加强术后监测,并考虑减少失血策略和个体化输血实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Intraoperative estimated blood loss (EBL) and need for perioperative packed red blood cell (pRBC) transfusion are common during lower extremity bypass (LEB) for chronic limb-threatening ischemia (CLTI) and have each been associated with adverse postoperative outcomes. However, their joint associations with postoperative outcomes remain incompletely defined. This study aimed to evaluate the associations of EBL and perioperative pRBC transfusion, individually and jointly, with postoperative morbidity and mortality in patients undergoing LEB for CLTI. METHODS: A retrospective cohort study was conducted using the Society for Vascular Surgery Vascular Quality Initiative (VQI) database. Patients undergoing LEB for CLTI between 2014 and 2023 were identified. Receiver operating characteristic analysis identified an optimal EBL threshold of 225 mL (area under the curve 0.72) for predicting transfusion, which was used to stratify patients into low-EBL (<225 mL) and high-EBL (≥225 mL) groups. Primary outcomes included myocardial infarction (MI), stroke, 30-day mortality, and a composite endpoint. Multivariable logistic regression was used to assess adjusted associations across four groups defined by EBL and transfusion status. Separate model was used to evaluate the interaction between EBL and pRBC transfusion. RESULTS: Among 36,019 procedures, 58.5% had low EBL and 41.5% had high EBL. Patients who had high EBL and did not require blood transfusion had increased odds of adverse postoperative outcomes, including 30-day mortality (AOR 1.26, 95% CI [1.01, 1.59]), myocardial infarction (AOR 1.88, 95% CI [1.48, 2.39]), stroke (AOR 1.58, 95% CI [1.09, 2.29]), and the composite outcome (AOR 1.51, 95% CI [1.29, 1.78]). Patients who had low EBL and received blood transfusion had increased odds of 30-day mortality (AOR 2.46, 95% CI [1.95, 3.10]), myocardial infarction (AOR 6.57, 95% CI [5.26, 8.21]), stroke (AOR 2.75, 95% CI [1.84, 4.12]), and the composite outcome (AOR 4.08, 95% CI [3.48, 4.78]). Patients who had both high EBL and required perioperative blood transfusion demonstrated the highest odds of adverse outcomes, including 30-day mortality (AOR 2.54, 95% CI [2.09, 3.08]), myocardial infarction (AOR 7.39, 95% CI [6.08, 8.98]), stroke (AOR 3.79, 95% CI [2.76, 5.21]), and the composite outcome (AOR 4.42, 95% CI [3.87, 5.05]). Formal interaction testing demonstrated significant between EBL and transfusion. CONCLUSION: In patients undergoing LEB for CLTI, intraoperative EBL and perioperative pRBC transfusion were both independently and jointly associated with increased postoperative morbidity and mortality. These findings identify EBL and transfusion as markers of perioperative risk and support further investigation of blood-sparing strategies and individualized transfusion practices.
引用
- Samaan, Perry, Soucy, et al. Intraoperative Estimated Blood Loss and Perioperative Transfusion are Independently Associated with Postoperative Morbidity and Mortality After Lower Extremity Bypass. J Vasc Surg. 2026. PMID: 42951051. doi:10.1016/j.jvs.2026.10.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。